Ian Ying Woo Exercises Options at NovaBridge Biosciences (NBP) — SEC Form 4, Oct 19, 2026
SEC Form 4 · No Market Transaction
Option Exercise
Derivative exercise — no open market transaction.
Equity Position
13.3K sh
0 → 13,271
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Ian Ying Woo CIK 0002115245 |
Director
|
Non-Derivative Securities Transactions
Derivative Securities Transactions
Footnotes (6)
- F1
- The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer. Show more
- F2
- Reported securities are represented by 5,770 ADSs. Show more
- F3
- Each restricted stock unit ("RSU") represents a contingent right to receive one ADS. Show more
- F4
- Reported securities represent ADSs. Show more
- F5
- On October 15, 2025, the Reporting Person was granted 17,310 restricted share units ("RSUs"). The RSUs vest or shall vest over three years in equal annual installments on October 15, 2026, 2027 and 2028. Show more
- F6
- Reported securities represent ADSs. Show more
Related filings at NovaBridge Biosciences
Institutional Holders
13F holders · Sep 30, 2026
47
institutional managers reporting a position
Largest by reported value
- Hhlr Advisors, Ltd. $8.16M
- Morgan Stanley $4.74M
- Aihc Capital Management Ltd $3.93M
5%+ Holders · 13D/G
3 filers
-
Hhlr Advisors, Ltd. 4.9%
Other insiders at NovaBridge Biosciences
-
Phillip Andrew Dennis -$5.83K
-
Sean Wuxiong Cao -$79.9K
-
Cong Claire Xu -$2.59K
GET /v1/forms/4/0002115245-26-000004
API docs
View Original SEC Filing